Altered Oral Nitrate Reduction and Bacterial Profiles in Hypertensive Women Predict Blood Pressure Lowering Following Acute Dietary Nitrate Supplementation.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
11 2023
Historique:
medline: 23 10 2023
pubmed: 13 9 2023
entrez: 13 9 2023
Statut: ppublish

Résumé

The efficacy of dietary nitrate supplementation to lower blood pressure (BP) in pregnant women is highly variable. We aimed to investigate whether differences in oral microbiota profiles and oral nitrate-reducing capacity may explain interindividual differences in BP lowering following nitrate supplementation. Participants recruited for this study were both pregnant and nonpregnant women, with or without hypertension (n=55). Following an overnight fast, plasma, saliva, and tongue scraping samples were collected for measurement of nitrate/nitrite concentrations, oral NaR (nitrate reductase) activity, and microbiota profiling using 16S rRNA gene sequencing. Baseline BP was measured, followed by the administration of a single dose of dietary nitrate (400 mg nitrate in 70 mL beetroot juice). Post-nitrate intervention, plasma and salivary nitrate/nitrite concentrations and BP were determined 2.5 hours later. Women with hypertension had significantly lower salivary nitrite concentrations ( The abundance and activity of oral nitrate-reducing bacteria impact both baseline BP as well as the ability of dietary nitrate supplementation to lower BP. Strategies to increase oral nitrate-reducing capacity could lower BP and enhance the efficacy of dietary nitrate supplementation, in pregnancy as well as in nonpregnant adults. URL: https://www. gov; Unique identifier: NCT03930693.

Sections du résumé

BACKGROUND
The efficacy of dietary nitrate supplementation to lower blood pressure (BP) in pregnant women is highly variable. We aimed to investigate whether differences in oral microbiota profiles and oral nitrate-reducing capacity may explain interindividual differences in BP lowering following nitrate supplementation.
METHODS
Participants recruited for this study were both pregnant and nonpregnant women, with or without hypertension (n=55). Following an overnight fast, plasma, saliva, and tongue scraping samples were collected for measurement of nitrate/nitrite concentrations, oral NaR (nitrate reductase) activity, and microbiota profiling using 16S rRNA gene sequencing. Baseline BP was measured, followed by the administration of a single dose of dietary nitrate (400 mg nitrate in 70 mL beetroot juice). Post-nitrate intervention, plasma and salivary nitrate/nitrite concentrations and BP were determined 2.5 hours later.
RESULTS
Women with hypertension had significantly lower salivary nitrite concentrations (
CONCLUSIONS
The abundance and activity of oral nitrate-reducing bacteria impact both baseline BP as well as the ability of dietary nitrate supplementation to lower BP. Strategies to increase oral nitrate-reducing capacity could lower BP and enhance the efficacy of dietary nitrate supplementation, in pregnancy as well as in nonpregnant adults.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT03930693.

Identifiants

pubmed: 37702047
doi: 10.1161/HYPERTENSIONAHA.123.21263
doi:

Substances chimiques

Nitrates 0
Nitrites 0
RNA, Ribosomal, 16S 0

Banques de données

ClinicalTrials.gov
['NCT03930693']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2397-2406

Auteurs

Thomas Willmott (T)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences (T.W., L.O., J.E.M., E.C.C.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.
Division of Pharmacy and Optometry, School of Health Sciences (T.W., A.J.M., G.J.H.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Laura Ormesher (L)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences (T.W., L.O., J.E.M., E.C.C.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Andrew J McBain (AJ)

Division of Pharmacy and Optometry, School of Health Sciences (T.W., A.J.M., G.J.H.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Gavin J Humphreys (GJ)

Division of Pharmacy and Optometry, School of Health Sciences (T.W., A.J.M., G.J.H.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Jenny E Myers (JE)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences (T.W., L.O., J.E.M., E.C.C.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Gurdeep Singh (G)

Lydia Becker Institute of Immunology and Inflammation, Manchester Academic Health Science Centre (G.S.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Jon O Lundberg (JO)

Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (J.O.L., E.W., C.N.).

Eddie Weitzberg (E)

Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (J.O.L., E.W., C.N.).

Carina Nihlen (C)

Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (J.O.L., E.W., C.N.).

Elizabeth C Cottrell (EC)

Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, School of Medical Sciences (T.W., L.O., J.E.M., E.C.C.), Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH